Entry,Name,Position,Pathways
7157,['(RefSeq) tumor protein p53'],17p13.1,"[('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04137', 'Mitophagy - animal'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04216', 'Ferroptosis'), ('hsa04218', 'Cellular senescence'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa05012', 'Parkinson disease'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05016', 'Huntington disease'), ('hsa05131', 'Shigellosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05210', 'Colorectal cancer'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05216', 'Thyroid cancer'), ('hsa05217', 'Basal cell carcinoma'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
7337,['(RefSeq) ubiquitin protein ligase E3A'],15q11.2,"[('hsa04120', 'Ubiquitin mediated proteolysis'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05203', 'Viral carcinogenesis')]"
1739,['(RefSeq) discs large MAGUK scaffold protein 1'],3q29,"[('hsa04390', 'Hippo signaling pathway'), ('hsa04530', 'Tight junction'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
23513,['(RefSeq) scribble planar cell polarity protein'],8q24.3,"[('hsa04390', 'Hippo signaling pathway'), ('hsa04530', 'Tight junction'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05203', 'Viral carcinogenesis')]"
5829,['(RefSeq) paxillin'],12q24.23,"[('hsa04062', 'Chemokine signaling pathway'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04510', 'Focal adhesion'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer')]"
578,['(RefSeq) BCL2 antagonist/killer 1'],6p21.31,"[('hsa01524', 'Platinum drug resistance'), ('hsa04141', 'Protein processing in endoplasmic reticulum'), ('hsa04210', 'Apoptosis'), ('hsa04215', 'Apoptosis - multiple species'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05132', 'Salmonella infection'), ('hsa05160', 'Hepatitis C'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05210', 'Colorectal cancer'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05216', 'Thyroid cancer'), ('hsa05217', 'Basal cell carcinoma'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer')]"
3661,['(RefSeq) interferon regulatory factor 3'],19q13.33,"[('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa04623', 'Cytosolic DNA-sensing pathway'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05131', 'Shigellosis'), ('hsa05133', 'Pertussis'), ('hsa05135', 'Yersinia infection'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05417', 'Lipid and atherosclerosis')]"
5925,['(RefSeq) RB transcriptional corepressor 1'],13q14.2,"[('hsa01522', 'Endocrine resistance'), ('hsa04110', 'Cell cycle'), ('hsa04218', 'Cellular senescence'), ('hsa04934', 'Cushing syndrome'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05212', 'Pancreatic cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer')]"
5933,['(RefSeq) RB transcriptional corepressor like 1'],20q11.23,"[('hsa04110', 'Cell cycle'), ('hsa04218', 'Cellular senescence'), ('hsa04350', 'TGF-beta signaling pathway'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05203', 'Viral carcinogenesis')]"
5934,['(RefSeq) RB transcriptional corepressor like 2'],16q12.2,"[('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05203', 'Viral carcinogenesis')]"
387332,['(RefSeq) TATA-box binding protein like 2'],14q22.3,"[('hsa03022', 'Basal transcription factors'), ('hsa05016', 'Huntington disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
6908,['(RefSeq) TATA-box binding protein'],6q27,"[('hsa03022', 'Basal transcription factors'), ('hsa05016', 'Huntington disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
9519,['(RefSeq) TATA-box binding protein like 1'],6q23.2,"[('hsa03022', 'Basal transcription factors'), ('hsa05016', 'Huntington disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
5700,"['(RefSeq) proteasome 26S subunit, ATPase 1']",14q32.11,"[('hsa03050', 'Proteasome'), ('hsa05010', 'Alzheimer disease'), ('hsa05012', 'Parkinson disease'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05016', 'Huntington disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05203', 'Viral carcinogenesis')]"
1108,['(RefSeq) chromodomain helicase DNA binding protein 4'],12p13.31,"[('hsa05165', 'Human papillomavirus infection'), ('hsa05203', 'Viral carcinogenesis')]"
3725,"['(RefSeq) Jun proto-oncogene, AP-1 transcription factor subunit']",1p32.1,"[('hsa01522', 'Endocrine resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04137', 'Mitophagy - animal'), ('hsa04210', 'Apoptosis'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04530', 'Tight junction'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa04659', 'Th17 cell differentiation'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04912', 'GnRH signaling pathway'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04921', 'Oxytocin signaling pathway'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05120', 'Epithelial cell signaling in Helicobacter pylori infection'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05133', 'Pertussis'), ('hsa05135', 'Yersinia infection'), ('hsa05140', 'Leishmaniasis'), ('hsa05142', 'Chagas disease'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05224', 'Breast cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05321', 'Inflammatory bowel disease'), ('hsa05323', 'Rheumatoid arthritis'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
10379,['(RefSeq) interferon regulatory factor 9'],14q12,"[('hsa04217', 'Necroptosis'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa05160', 'Hepatitis C'), ('hsa05162', 'Measles'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05203', 'Viral carcinogenesis')]"
7157,['(RefSeq) tumor protein p53'],17p13.1,"[('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04137', 'Mitophagy - animal'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04216', 'Ferroptosis'), ('hsa04218', 'Cellular senescence'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa05012', 'Parkinson disease'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05016', 'Huntington disease'), ('hsa05131', 'Shigellosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05210', 'Colorectal cancer'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05216', 'Thyroid cancer'), ('hsa05217', 'Basal cell carcinoma'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
7157,['(RefSeq) tumor protein p53'],17p13.1,"[('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04137', 'Mitophagy - animal'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04216', 'Ferroptosis'), ('hsa04218', 'Cellular senescence'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa05012', 'Parkinson disease'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05016', 'Huntington disease'), ('hsa05131', 'Shigellosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05210', 'Colorectal cancer'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05216', 'Thyroid cancer'), ('hsa05217', 'Basal cell carcinoma'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
836,['(RefSeq) caspase 3'],4q35.1,"[('hsa01524', 'Platinum drug resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04115', 'p53 signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04215', 'Apoptosis - multiple species'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa04726', 'Serotonergic synapse'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05010', 'Alzheimer disease'), ('hsa05012', 'Parkinson disease'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05016', 'Huntington disease'), ('hsa05020', 'Prion disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05120', 'Epithelial cell signaling in Helicobacter pylori infection'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05132', 'Salmonella infection'), ('hsa05133', 'Pertussis'), ('hsa05134', 'Legionellosis'), ('hsa05145', 'Toxoplasmosis'), ('hsa05146', 'Amoebiasis'), ('hsa05152', 'Tuberculosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05210', 'Colorectal cancer'), ('hsa05222', 'Small cell lung cancer'), ('hsa05416', 'Viral myocarditis'), ('hsa05417', 'Lipid and atherosclerosis')]"
841,['(RefSeq) caspase 8'],2q33.1,"[('hsa01524', 'Platinum drug resistance'), ('hsa04115', 'p53 signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04215', 'Apoptosis - multiple species'), ('hsa04217', 'Necroptosis'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05010', 'Alzheimer disease'), ('hsa05016', 'Huntington disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05132', 'Salmonella infection'), ('hsa05134', 'Legionellosis'), ('hsa05142', 'Chagas disease'), ('hsa05145', 'Toxoplasmosis'), ('hsa05152', 'Tuberculosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05416', 'Viral myocarditis'), ('hsa05417', 'Lipid and atherosclerosis')]"
8517,['(RefSeq) inhibitor of nuclear factor kappa B kinase regulatory subunit gamma'],Xq28,"[('hsa01523', 'Antifolate resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa04623', 'Cytosolic DNA-sensing pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa04659', 'Th17 cell differentiation'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa04920', 'Adipocytokine signaling pathway'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05010', 'Alzheimer disease'), ('hsa05120', 'Epithelial cell signaling in Helicobacter pylori infection'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05145', 'Toxoplasmosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05212', 'Pancreatic cancer'), ('hsa05215', 'Prostate cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05340', 'Primary immunodeficiency'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
581,"['(RefSeq) BCL2 associated X, apoptosis regulator']",19q13.33,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04115', 'p53 signaling pathway'), ('hsa04141', 'Protein processing in endoplasmic reticulum'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04215', 'Apoptosis - multiple species'), ('hsa04217', 'Necroptosis'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa05012', 'Parkinson disease'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05016', 'Huntington disease'), ('hsa05020', 'Prion disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05152', 'Tuberculosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05210', 'Colorectal cancer'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05216', 'Thyroid cancer'), ('hsa05217', 'Basal cell carcinoma'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05417', 'Lipid and atherosclerosis')]"
572,['(RefSeq) BCL2 associated agonist of cell death'],11q13.1,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04510', 'Focal adhesion'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa05010', 'Alzheimer disease'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05020', 'Prion disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05145', 'Toxoplasmosis'), ('hsa05152', 'Tuberculosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05417', 'Lipid and atherosclerosis')]"
5366,['(RefSeq) phorbol-12-myristate-13-acetate-induced protein 1'],18q21.32,"[('hsa01524', 'Platinum drug resistance'), ('hsa04115', 'p53 signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04215', 'Apoptosis - multiple species'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05210', 'Colorectal cancer')]"
7157,['(RefSeq) tumor protein p53'],17p13.1,"[('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04137', 'Mitophagy - animal'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04216', 'Ferroptosis'), ('hsa04218', 'Cellular senescence'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa05012', 'Parkinson disease'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05016', 'Huntington disease'), ('hsa05131', 'Shigellosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05210', 'Colorectal cancer'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05216', 'Thyroid cancer'), ('hsa05217', 'Basal cell carcinoma'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
5925,['(RefSeq) RB transcriptional corepressor 1'],13q14.2,"[('hsa01522', 'Endocrine resistance'), ('hsa04110', 'Cell cycle'), ('hsa04218', 'Cellular senescence'), ('hsa04934', 'Cushing syndrome'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05212', 'Pancreatic cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer')]"
7185,['(RefSeq) TNF receptor associated factor 1'],9q33.2,"[('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05222', 'Small cell lung cancer')]"
7186,['(RefSeq) TNF receptor associated factor 2'],9q34.3,"[('hsa04010', 'MAPK signaling pathway'), ('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04141', 'Protein processing in endoplasmic reticulum'), ('hsa04210', 'Apoptosis'), ('hsa04217', 'Necroptosis'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa04920', 'Adipocytokine signaling pathway'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa05010', 'Alzheimer disease'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05016', 'Huntington disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05135', 'Yersinia infection'), ('hsa05160', 'Hepatitis C'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05222', 'Small cell lung cancer'), ('hsa05417', 'Lipid and atherosclerosis')]"
7187,['(RefSeq) TNF receptor associated factor 3'],14q32.32,"[('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05222', 'Small cell lung cancer'), ('hsa05417', 'Lipid and atherosclerosis')]"
7188,['(RefSeq) TNF receptor associated factor 5'],1q32.3,"[('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04217', 'Necroptosis'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa05131', 'Shigellosis'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05222', 'Small cell lung cancer')]"
6714,"['(RefSeq) SRC proto-oncogene, non-receptor tyrosine kinase']",20q11.23,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04137', 'Mitophagy - animal'), ('hsa04144', 'Endocytosis'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04510', 'Focal adhesion'), ('hsa04520', 'Adherens junction'), ('hsa04530', 'Tight junction'), ('hsa04540', 'Gap junction'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04727', 'GABAergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04912', 'GnRH signaling pathway'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04921', 'Oxytocin signaling pathway'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05120', 'Epithelial cell signaling in Helicobacter pylori infection'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05152', 'Tuberculosis'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05219', 'Bladder cancer'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
1642,['(RefSeq) damage specific DNA binding protein 1'],11q12.2,"[('hsa03420', 'Nucleotide excision repair'), ('hsa04120', 'Ubiquitin mediated proteolysis'), ('hsa05161', 'Hepatitis B'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
5594,['(RefSeq) mitogen-activated protein kinase 1'],22q11.22,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04114', 'Oocyte meiosis'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04218', 'Cellular senescence'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04270', 'Vascular smooth muscle contraction'), ('hsa04350', 'TGF-beta signaling pathway'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04371', 'Apelin signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04520', 'Adherens junction'), ('hsa04540', 'Gap junction'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa04659', 'Th17 cell differentiation'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04713', 'Circadian entrainment'), ('hsa04720', 'Long-term potentiation'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04723', 'Retrograde endocannabinoid signaling'), ('hsa04724', 'Glutamatergic synapse'), ('hsa04725', 'Cholinergic synapse'), ('hsa04726', 'Serotonergic synapse'), ('hsa04730', 'Long-term depression'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04912', 'GnRH signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04921', 'Oxytocin signaling pathway'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05020', 'Prion disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05034', 'Alcoholism'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05133', 'Pertussis'), ('hsa05135', 'Yersinia infection'), ('hsa05140', 'Leishmaniasis'), ('hsa05142', 'Chagas disease'), ('hsa05145', 'Toxoplasmosis'), ('hsa05152', 'Tuberculosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05216', 'Thyroid cancer'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05417', 'Lipid and atherosclerosis')]"
5595,['(RefSeq) mitogen-activated protein kinase 3'],16p11.2,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04114', 'Oocyte meiosis'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04218', 'Cellular senescence'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04270', 'Vascular smooth muscle contraction'), ('hsa04350', 'TGF-beta signaling pathway'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04371', 'Apelin signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04520', 'Adherens junction'), ('hsa04540', 'Gap junction'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa04659', 'Th17 cell differentiation'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04713', 'Circadian entrainment'), ('hsa04720', 'Long-term potentiation'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04723', 'Retrograde endocannabinoid signaling'), ('hsa04724', 'Glutamatergic synapse'), ('hsa04725', 'Cholinergic synapse'), ('hsa04726', 'Serotonergic synapse'), ('hsa04730', 'Long-term depression'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04912', 'GnRH signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04921', 'Oxytocin signaling pathway'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05020', 'Prion disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05034', 'Alcoholism'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05133', 'Pertussis'), ('hsa05135', 'Yersinia infection'), ('hsa05140', 'Leishmaniasis'), ('hsa05142', 'Chagas disease'), ('hsa05145', 'Toxoplasmosis'), ('hsa05152', 'Tuberculosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05216', 'Thyroid cancer'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05417', 'Lipid and atherosclerosis')]"
10488,['(RefSeq) cAMP responsive element binding protein 3'],9p13.3,"[('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04668', 'TNF signaling pathway'), ('hsa04714', 'Thermogenesis'), ('hsa04725', 'Cholinergic synapse'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04931', 'Insulin resistance'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04962', 'Vasopressin-regulated water reabsorption'), ('hsa05016', 'Huntington disease'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05215', 'Prostate cancer')]"
1385,['(RefSeq) cAMP responsive element binding protein 1'],2q33.3,"[('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04612', 'Antigen processing and presentation'), ('hsa04668', 'TNF signaling pathway'), ('hsa04710', 'Circadian rhythm'), ('hsa04713', 'Circadian entrainment'), ('hsa04714', 'Thermogenesis'), ('hsa04725', 'Cholinergic synapse'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04924', 'Renin secretion'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04931', 'Insulin resistance'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04962', 'Vasopressin-regulated water reabsorption'), ('hsa05016', 'Huntington disease'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05152', 'Tuberculosis'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05215', 'Prostate cancer')]"
1386,['(RefSeq) activating transcription factor 2'],2q31.1,"[('hsa04010', 'MAPK signaling pathway'), ('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04668', 'TNF signaling pathway'), ('hsa04714', 'Thermogenesis'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation')]"
1388,['(RefSeq) activating transcription factor 6 beta'],6p21.32,"[('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04141', 'Protein processing in endoplasmic reticulum'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04668', 'TNF signaling pathway'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation')]"
148327,['(RefSeq) cAMP responsive element binding protein 3 like 4'],1q21.3,"[('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04668', 'TNF signaling pathway'), ('hsa04714', 'Thermogenesis'), ('hsa04725', 'Cholinergic synapse'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04931', 'Insulin resistance'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04962', 'Vasopressin-regulated water reabsorption'), ('hsa05016', 'Huntington disease'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05215', 'Prostate cancer')]"
468,['(RefSeq) activating transcription factor 4'],22q13.1,"[('hsa04010', 'MAPK signaling pathway'), ('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04137', 'Mitophagy - animal'), ('hsa04141', 'Protein processing in endoplasmic reticulum'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04668', 'TNF signaling pathway'), ('hsa04720', 'Long-term potentiation'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04912', 'GnRH signaling pathway'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05010', 'Alzheimer disease'), ('hsa05012', 'Parkinson disease'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05020', 'Prion disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05215', 'Prostate cancer'), ('hsa05417', 'Lipid and atherosclerosis')]"
64764,['(RefSeq) cAMP responsive element binding protein 3 like 2'],7q33,"[('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04668', 'TNF signaling pathway'), ('hsa04714', 'Thermogenesis'), ('hsa04725', 'Cholinergic synapse'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04931', 'Insulin resistance'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04962', 'Vasopressin-regulated water reabsorption'), ('hsa05016', 'Huntington disease'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05215', 'Prostate cancer')]"
84699,['(RefSeq) cAMP responsive element binding protein 3 like 3'],19p13.3,"[('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04668', 'TNF signaling pathway'), ('hsa04714', 'Thermogenesis'), ('hsa04725', 'Cholinergic synapse'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04931', 'Insulin resistance'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04962', 'Vasopressin-regulated water reabsorption'), ('hsa05016', 'Huntington disease'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05215', 'Prostate cancer')]"
90993,['(RefSeq) cAMP responsive element binding protein 3 like 1'],11p11.2,"[('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04668', 'TNF signaling pathway'), ('hsa04714', 'Thermogenesis'), ('hsa04725', 'Cholinergic synapse'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04931', 'Insulin resistance'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04962', 'Vasopressin-regulated water reabsorption'), ('hsa05016', 'Huntington disease'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05215', 'Prostate cancer')]"
9586,['(RefSeq) cAMP responsive element binding protein 5'],7p15.1-p14.3,"[('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04668', 'TNF signaling pathway'), ('hsa04714', 'Thermogenesis'), ('hsa04725', 'Cholinergic synapse'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04931', 'Insulin resistance'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04962', 'Vasopressin-regulated water reabsorption'), ('hsa05016', 'Huntington disease'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05215', 'Prostate cancer')]"
3716,['(RefSeq) Janus kinase 1'],1p31.3,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04217', 'Necroptosis'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa04659', 'Th17 cell differentiation'), ('hsa05140', 'Leishmaniasis'), ('hsa05145', 'Toxoplasmosis'), ('hsa05152', 'Tuberculosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05212', 'Pancreatic cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer')]"
6774,['(RefSeq) signal transducer and activator of transcription 3'],17q21.2,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04217', 'Necroptosis'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04659', 'Th17 cell differentiation'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04920', 'Adipocytokine signaling pathway'), ('hsa04931', 'Insulin resistance'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05145', 'Toxoplasmosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05212', 'Pancreatic cancer'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05321', 'Inflammatory bowel disease'), ('hsa05417', 'Lipid and atherosclerosis')]"
6776,['(RefSeq) signal transducer and activator of transcription 5A'],17q21.2,"[('hsa04012', 'ErbB signaling pathway'), ('hsa04217', 'Necroptosis'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa04659', 'Th17 cell differentiation'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05223', 'Non-small cell lung cancer')]"
6777,['(RefSeq) signal transducer and activator of transcription 5B'],17q21.2,"[('hsa04012', 'ErbB signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04217', 'Necroptosis'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa04659', 'Th17 cell differentiation'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05223', 'Non-small cell lung cancer')]"
5290,"['(RefSeq) phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha']",3q26.32,"[('hsa00562', 'Inositol phosphate metabolism'), ('hsa01100', 'Metabolic pathways'), ('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
5291,"['(RefSeq) phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta']",3q22.3,"[('hsa00562', 'Inositol phosphate metabolism'), ('hsa01100', 'Metabolic pathways'), ('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
5293,"['(RefSeq) phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta']",1p36.22,"[('hsa00562', 'Inositol phosphate metabolism'), ('hsa01100', 'Metabolic pathways'), ('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
5295,['(RefSeq) phosphoinositide-3-kinase regulatory subunit 1'],5q13.1,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
5296,['(RefSeq) phosphoinositide-3-kinase regulatory subunit 2'],19p13.11,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
8503,['(RefSeq) phosphoinositide-3-kinase regulatory subunit 3'],1p34.1,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
4790,['(RefSeq) nuclear factor kappa B subunit 1'],4q24,"[('hsa01523', 'Antifolate resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa04623', 'Cytosolic DNA-sensing pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa04659', 'Th17 cell differentiation'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04920', 'Adipocytokine signaling pathway'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05010', 'Alzheimer disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05030', 'Cocaine addiction'), ('hsa05120', 'Epithelial cell signaling in Helicobacter pylori infection'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05133', 'Pertussis'), ('hsa05134', 'Legionellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05140', 'Leishmaniasis'), ('hsa05142', 'Chagas disease'), ('hsa05145', 'Toxoplasmosis'), ('hsa05146', 'Amoebiasis'), ('hsa05152', 'Tuberculosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05212', 'Pancreatic cancer'), ('hsa05215', 'Prostate cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05321', 'Inflammatory bowel disease'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
4791,['(RefSeq) nuclear factor kappa B subunit 2'],10q24.32,"[('hsa04010', 'MAPK signaling pathway'), ('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa05134', 'Legionellosis'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05224', 'Breast cancer')]"
5966,"['(RefSeq) REL proto-oncogene, NF-kB subunit']",2p16.1,"[('hsa04014', 'Ras signaling pathway'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis')]"
5970,"['(RefSeq) RELA proto-oncogene, NF-kB subunit']",11q13.1,"[('hsa01523', 'Antifolate resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04137', 'Mitophagy - animal'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa04623', 'Cytosolic DNA-sensing pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa04659', 'Th17 cell differentiation'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04920', 'Adipocytokine signaling pathway'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05010', 'Alzheimer disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05030', 'Cocaine addiction'), ('hsa05120', 'Epithelial cell signaling in Helicobacter pylori infection'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05133', 'Pertussis'), ('hsa05134', 'Legionellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05140', 'Leishmaniasis'), ('hsa05142', 'Chagas disease'), ('hsa05145', 'Toxoplasmosis'), ('hsa05146', 'Amoebiasis'), ('hsa05152', 'Tuberculosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05212', 'Pancreatic cancer'), ('hsa05215', 'Prostate cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05321', 'Inflammatory bowel disease'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
1959,['(RefSeq) early growth response 2'],10q21.3,"[('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa05161', 'Hepatitis B'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
1960,['(RefSeq) early growth response 3'],8p21.3,"[('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa05161', 'Hepatitis B'), ('hsa05203', 'Viral carcinogenesis')]"
7157,['(RefSeq) tumor protein p53'],17p13.1,"[('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04137', 'Mitophagy - animal'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04216', 'Ferroptosis'), ('hsa04218', 'Cellular senescence'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa05012', 'Parkinson disease'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05016', 'Huntington disease'), ('hsa05131', 'Shigellosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05210', 'Colorectal cancer'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05216', 'Thyroid cancer'), ('hsa05217', 'Basal cell carcinoma'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
1017,['(RefSeq) cyclin dependent kinase 2'],12q13.2,"[('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04114', 'Oocyte meiosis'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04934', 'Cushing syndrome'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05215', 'Prostate cancer'), ('hsa05222', 'Small cell lung cancer'), ('hsa05226', 'Gastric cancer')]"
1019,['(RefSeq) cyclin dependent kinase 4'],12q14.1,"[('hsa01522', 'Endocrine resistance'), ('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04530', 'Tight junction'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04934', 'Cushing syndrome'), ('hsa05160', 'Hepatitis C'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05212', 'Pancreatic cancer'), ('hsa05214', 'Glioma'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma')]"
1021,['(RefSeq) cyclin dependent kinase 6'],7q21.2,"[('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04934', 'Cushing syndrome'), ('hsa05160', 'Hepatitis C'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05212', 'Pancreatic cancer'), ('hsa05214', 'Glioma'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma')]"
1029,['(RefSeq) cyclin dependent kinase inhibitor 2A'],9p21.3,"[('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04934', 'Cushing syndrome'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05212', 'Pancreatic cancer'), ('hsa05214', 'Glioma'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05225', 'Hepatocellular carcinoma')]"
1030,['(RefSeq) cyclin dependent kinase inhibitor 2B'],9p21.3,"[('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04218', 'Cellular senescence'), ('hsa04350', 'TGF-beta signaling pathway'), ('hsa04934', 'Cushing syndrome'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05222', 'Small cell lung cancer'), ('hsa05226', 'Gastric cancer')]"
5925,['(RefSeq) RB transcriptional corepressor 1'],13q14.2,"[('hsa01522', 'Endocrine resistance'), ('hsa04110', 'Cell cycle'), ('hsa04218', 'Cellular senescence'), ('hsa04934', 'Cushing syndrome'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05212', 'Pancreatic cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer')]"
1739,['(RefSeq) discs large MAGUK scaffold protein 1'],3q29,"[('hsa04390', 'Hippo signaling pathway'), ('hsa04530', 'Tight junction'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
5423,['(RefSeq) DNA polymerase beta'],8p11.21,"[('hsa03410', 'Base excision repair'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
7157,['(RefSeq) tumor protein p53'],17p13.1,"[('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04137', 'Mitophagy - animal'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04216', 'Ferroptosis'), ('hsa04218', 'Cellular senescence'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa05012', 'Parkinson disease'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05016', 'Huntington disease'), ('hsa05131', 'Shigellosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05210', 'Colorectal cancer'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05216', 'Thyroid cancer'), ('hsa05217', 'Basal cell carcinoma'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
8379,['(RefSeq) mitotic arrest deficient 1 like 1'],7p22.3,"[('hsa04110', 'Cell cycle'), ('hsa04114', 'Oocyte meiosis'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
55697,['(RefSeq) VAC14 component of PIKFYVE complex'],16q22.1-q22.2,"[('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
5902,['(RefSeq) RAN binding protein 1'],22q11.21,"[('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
2648,['(RefSeq) lysine acetyltransferase 2A'],17q21.2,"[('hsa04330', 'Notch signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
8850,['(RefSeq) lysine acetyltransferase 2B'],3p24.3,"[('hsa04330', 'Notch signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
10488,['(RefSeq) cAMP responsive element binding protein 3'],9p13.3,"[('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04668', 'TNF signaling pathway'), ('hsa04714', 'Thermogenesis'), ('hsa04725', 'Cholinergic synapse'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04931', 'Insulin resistance'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04962', 'Vasopressin-regulated water reabsorption'), ('hsa05016', 'Huntington disease'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05215', 'Prostate cancer')]"
1385,['(RefSeq) cAMP responsive element binding protein 1'],2q33.3,"[('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04612', 'Antigen processing and presentation'), ('hsa04668', 'TNF signaling pathway'), ('hsa04710', 'Circadian rhythm'), ('hsa04713', 'Circadian entrainment'), ('hsa04714', 'Thermogenesis'), ('hsa04725', 'Cholinergic synapse'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04924', 'Renin secretion'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04931', 'Insulin resistance'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04962', 'Vasopressin-regulated water reabsorption'), ('hsa05016', 'Huntington disease'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05152', 'Tuberculosis'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05215', 'Prostate cancer')]"
1386,['(RefSeq) activating transcription factor 2'],2q31.1,"[('hsa04010', 'MAPK signaling pathway'), ('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04668', 'TNF signaling pathway'), ('hsa04714', 'Thermogenesis'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation')]"
1388,['(RefSeq) activating transcription factor 6 beta'],6p21.32,"[('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04141', 'Protein processing in endoplasmic reticulum'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04668', 'TNF signaling pathway'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation')]"
148327,['(RefSeq) cAMP responsive element binding protein 3 like 4'],1q21.3,"[('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04668', 'TNF signaling pathway'), ('hsa04714', 'Thermogenesis'), ('hsa04725', 'Cholinergic synapse'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04931', 'Insulin resistance'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04962', 'Vasopressin-regulated water reabsorption'), ('hsa05016', 'Huntington disease'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05215', 'Prostate cancer')]"
468,['(RefSeq) activating transcription factor 4'],22q13.1,"[('hsa04010', 'MAPK signaling pathway'), ('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04137', 'Mitophagy - animal'), ('hsa04141', 'Protein processing in endoplasmic reticulum'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04668', 'TNF signaling pathway'), ('hsa04720', 'Long-term potentiation'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04912', 'GnRH signaling pathway'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05010', 'Alzheimer disease'), ('hsa05012', 'Parkinson disease'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05020', 'Prion disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05215', 'Prostate cancer'), ('hsa05417', 'Lipid and atherosclerosis')]"
64764,['(RefSeq) cAMP responsive element binding protein 3 like 2'],7q33,"[('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04668', 'TNF signaling pathway'), ('hsa04714', 'Thermogenesis'), ('hsa04725', 'Cholinergic synapse'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04931', 'Insulin resistance'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04962', 'Vasopressin-regulated water reabsorption'), ('hsa05016', 'Huntington disease'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05215', 'Prostate cancer')]"
84699,['(RefSeq) cAMP responsive element binding protein 3 like 3'],19p13.3,"[('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04668', 'TNF signaling pathway'), ('hsa04714', 'Thermogenesis'), ('hsa04725', 'Cholinergic synapse'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04931', 'Insulin resistance'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04962', 'Vasopressin-regulated water reabsorption'), ('hsa05016', 'Huntington disease'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05215', 'Prostate cancer')]"
90993,['(RefSeq) cAMP responsive element binding protein 3 like 1'],11p11.2,"[('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04668', 'TNF signaling pathway'), ('hsa04714', 'Thermogenesis'), ('hsa04725', 'Cholinergic synapse'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04931', 'Insulin resistance'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04962', 'Vasopressin-regulated water reabsorption'), ('hsa05016', 'Huntington disease'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05215', 'Prostate cancer')]"
9586,['(RefSeq) cAMP responsive element binding protein 5'],7p15.1-p14.3,"[('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04668', 'TNF signaling pathway'), ('hsa04714', 'Thermogenesis'), ('hsa04725', 'Cholinergic synapse'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04911', 'Insulin secretion'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04931', 'Insulin resistance'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04962', 'Vasopressin-regulated water reabsorption'), ('hsa05016', 'Huntington disease'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05215', 'Prostate cancer')]"
6722,['(RefSeq) serum response factor'],6p21.1,"[('hsa04010', 'MAPK signaling pathway'), ('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
5290,"['(RefSeq) phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha']",3q26.32,"[('hsa00562', 'Inositol phosphate metabolism'), ('hsa01100', 'Metabolic pathways'), ('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
5291,"['(RefSeq) phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta']",3q22.3,"[('hsa00562', 'Inositol phosphate metabolism'), ('hsa01100', 'Metabolic pathways'), ('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
5293,"['(RefSeq) phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta']",1p36.22,"[('hsa00562', 'Inositol phosphate metabolism'), ('hsa01100', 'Metabolic pathways'), ('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
5295,['(RefSeq) phosphoinositide-3-kinase regulatory subunit 1'],5q13.1,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
5296,['(RefSeq) phosphoinositide-3-kinase regulatory subunit 2'],19p13.11,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
8503,['(RefSeq) phosphoinositide-3-kinase regulatory subunit 3'],1p34.1,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
8517,['(RefSeq) inhibitor of nuclear factor kappa B kinase regulatory subunit gamma'],Xq28,"[('hsa01523', 'Antifolate resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa04623', 'Cytosolic DNA-sensing pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa04659', 'Th17 cell differentiation'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa04920', 'Adipocytokine signaling pathway'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05010', 'Alzheimer disease'), ('hsa05120', 'Epithelial cell signaling in Helicobacter pylori infection'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05145', 'Toxoplasmosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05212', 'Pancreatic cancer'), ('hsa05215', 'Prostate cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05340', 'Primary immunodeficiency'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
8717,['(RefSeq) TNFRSF1A associated via death domain'],16q22.1,"[('hsa04010', 'MAPK signaling pathway'), ('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04217', 'Necroptosis'), ('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa04920', 'Adipocytokine signaling pathway'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05152', 'Tuberculosis'), ('hsa05160', 'Hepatitis C'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
7185,['(RefSeq) TNF receptor associated factor 1'],9q33.2,"[('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05222', 'Small cell lung cancer')]"
7186,['(RefSeq) TNF receptor associated factor 2'],9q34.3,"[('hsa04010', 'MAPK signaling pathway'), ('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04141', 'Protein processing in endoplasmic reticulum'), ('hsa04210', 'Apoptosis'), ('hsa04217', 'Necroptosis'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa04920', 'Adipocytokine signaling pathway'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa05010', 'Alzheimer disease'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05016', 'Huntington disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05135', 'Yersinia infection'), ('hsa05160', 'Hepatitis C'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05222', 'Small cell lung cancer'), ('hsa05417', 'Lipid and atherosclerosis')]"
7187,['(RefSeq) TNF receptor associated factor 3'],14q32.32,"[('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05222', 'Small cell lung cancer'), ('hsa05417', 'Lipid and atherosclerosis')]"
7188,['(RefSeq) TNF receptor associated factor 5'],1q32.3,"[('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04217', 'Necroptosis'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa05131', 'Shigellosis'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05222', 'Small cell lung cancer')]"
4067,"['(RefSeq) LYN proto-oncogene, Src family tyrosine kinase']",8q12.1,"[('hsa04062', 'Chemokine signaling pathway'), ('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04611', 'Platelet activation'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04730', 'Long-term depression'), ('hsa05120', 'Epithelial cell signaling in Helicobacter pylori infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05417', 'Lipid and atherosclerosis')]"
6850,['(RefSeq) spleen associated tyrosine kinase'],9q22.2,"[('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa05152', 'Tuberculosis'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05203', 'Viral carcinogenesis')]"
3718,['(RefSeq) Janus kinase 3'],19p13.11,"[('hsa04062', 'Chemokine signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04217', 'Necroptosis'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa04659', 'Th17 cell differentiation'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05340', 'Primary immunodeficiency')]"
7874,['(RefSeq) ubiquitin specific peptidase 7'],16p13.2,"[('hsa04068', 'FoxO signaling pathway'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05203', 'Viral carcinogenesis')]"
11317,['(RefSeq) recombination signal binding protein for immunoglobulin kappa J region like'],20q13.12,"[('hsa04330', 'Notch signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05203', 'Viral carcinogenesis')]"
3516,['(RefSeq) recombination signal binding protein for immunoglobulin kappa J region'],4p15.2,"[('hsa04330', 'Notch signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05203', 'Viral carcinogenesis')]"
7157,['(RefSeq) tumor protein p53'],17p13.1,"[('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04137', 'Mitophagy - animal'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04216', 'Ferroptosis'), ('hsa04218', 'Cellular senescence'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa05012', 'Parkinson disease'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05016', 'Huntington disease'), ('hsa05131', 'Shigellosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05210', 'Colorectal cancer'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05216', 'Thyroid cancer'), ('hsa05217', 'Basal cell carcinoma'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
595,['(RefSeq) cyclin D1'],11q13.3,"[('hsa01522', 'Endocrine resistance'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04340', 'Hedgehog signaling pathway'), ('hsa04371', 'Apelin signaling pathway'), ('hsa04390', 'Hippo signaling pathway'), ('hsa04510', 'Focal adhesion'), ('hsa04530', 'Tight junction'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04921', 'Oxytocin signaling pathway'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04934', 'Cushing syndrome'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05160', 'Hepatitis C'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05210', 'Colorectal cancer'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05216', 'Thyroid cancer'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05416', 'Viral myocarditis')]"
894,['(RefSeq) cyclin D2'],12p13.32,"[('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04340', 'Hedgehog signaling pathway'), ('hsa04390', 'Hippo signaling pathway'), ('hsa04510', 'Focal adhesion'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa05162', 'Measles'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer')]"
896,['(RefSeq) cyclin D3'],6p21.1,"[('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04390', 'Hippo signaling pathway'), ('hsa04510', 'Focal adhesion'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa05162', 'Measles'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation')]"
1021,['(RefSeq) cyclin dependent kinase 6'],7q21.2,"[('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04934', 'Cushing syndrome'), ('hsa05160', 'Hepatitis C'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05212', 'Pancreatic cancer'), ('hsa05214', 'Glioma'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma')]"
890,['(RefSeq) cyclin A2'],4q27,"[('hsa04110', 'Cell cycle'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa05161', 'Hepatitis B'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05221', 'Acute myeloid leukemia')]"
8900,['(RefSeq) cyclin A1'],13q13.3,"[('hsa04110', 'Cell cycle'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa05161', 'Hepatitis B'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05221', 'Acute myeloid leukemia')]"
1017,['(RefSeq) cyclin dependent kinase 2'],12q13.2,"[('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04114', 'Oocyte meiosis'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04934', 'Cushing syndrome'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05215', 'Prostate cancer'), ('hsa05222', 'Small cell lung cancer'), ('hsa05226', 'Gastric cancer')]"
4193,['(RefSeq) MDM2 proto-oncogene'],12q15,"[('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04120', 'Ubiquitin mediated proteolysis'), ('hsa04144', 'Endocytosis'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa05131', 'Shigellosis'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia')]"
28973,['(RefSeq) mitochondrial ribosomal protein S18B'],6p21.33,"[('hsa05203', 'Viral carcinogenesis')]"
898,['(RefSeq) cyclin E1'],19q12,"[('hsa04110', 'Cell cycle'), ('hsa04114', 'Oocyte meiosis'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04934', 'Cushing syndrome'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05215', 'Prostate cancer'), ('hsa05222', 'Small cell lung cancer'), ('hsa05226', 'Gastric cancer')]"
9134,['(RefSeq) cyclin E2'],8q22.1,"[('hsa04110', 'Cell cycle'), ('hsa04114', 'Oocyte meiosis'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04934', 'Cushing syndrome'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05215', 'Prostate cancer'), ('hsa05222', 'Small cell lung cancer'), ('hsa05226', 'Gastric cancer')]"
1017,['(RefSeq) cyclin dependent kinase 2'],12q13.2,"[('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04114', 'Oocyte meiosis'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04934', 'Cushing syndrome'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05215', 'Prostate cancer'), ('hsa05222', 'Small cell lung cancer'), ('hsa05226', 'Gastric cancer')]"
890,['(RefSeq) cyclin A2'],4q27,"[('hsa04110', 'Cell cycle'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa05161', 'Hepatitis B'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05221', 'Acute myeloid leukemia')]"
8900,['(RefSeq) cyclin A1'],13q13.3,"[('hsa04110', 'Cell cycle'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa05161', 'Hepatitis B'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05221', 'Acute myeloid leukemia')]"
1017,['(RefSeq) cyclin dependent kinase 2'],12q13.2,"[('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04114', 'Oocyte meiosis'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04934', 'Cushing syndrome'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05215', 'Prostate cancer'), ('hsa05222', 'Small cell lung cancer'), ('hsa05226', 'Gastric cancer')]"
23352,['(RefSeq) ubiquitin protein ligase E3 component n-recognin 4'],1p36.13,"[('hsa05165', 'Human papillomavirus infection'), ('hsa05203', 'Viral carcinogenesis')]"
3661,['(RefSeq) interferon regulatory factor 3'],19q13.33,"[('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa04623', 'Cytosolic DNA-sensing pathway'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05131', 'Shigellosis'), ('hsa05133', 'Pertussis'), ('hsa05135', 'Yersinia infection'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05417', 'Lipid and atherosclerosis')]"
1234,['(RefSeq) C-C motif chemokine receptor 5'],3p21.31,"[('hsa04060', 'Cytokine-cytokine receptor interaction'), ('hsa04061', 'Viral protein interaction with cytokine and cytokine receptor'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04144', 'Endocytosis'), ('hsa05145', 'Toxoplasmosis'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
1237,['(RefSeq) C-C motif chemokine receptor 8'],3p22.1,"[('hsa04060', 'Cytokine-cytokine receptor interaction'), ('hsa04061', 'Viral protein interaction with cytokine and cytokine receptor'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05203', 'Viral carcinogenesis')]"
1232,['(RefSeq) C-C motif chemokine receptor 3'],3p21.31,"[('hsa04060', 'Cytokine-cytokine receptor interaction'), ('hsa04061', 'Viral protein interaction with cytokine and cytokine receptor'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05203', 'Viral carcinogenesis')]"
1233,['(RefSeq) C-C motif chemokine receptor 4'],3p22.3,"[('hsa04060', 'Cytokine-cytokine receptor interaction'), ('hsa04061', 'Viral protein interaction with cytokine and cytokine receptor'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05203', 'Viral carcinogenesis')]"
3249,['(RefSeq) hepsin'],19q13.11,"[('hsa05203', 'Viral carcinogenesis')]"
898,['(RefSeq) cyclin E1'],19q12,"[('hsa04110', 'Cell cycle'), ('hsa04114', 'Oocyte meiosis'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04934', 'Cushing syndrome'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05215', 'Prostate cancer'), ('hsa05222', 'Small cell lung cancer'), ('hsa05226', 'Gastric cancer')]"
9134,['(RefSeq) cyclin E2'],8q22.1,"[('hsa04110', 'Cell cycle'), ('hsa04114', 'Oocyte meiosis'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04934', 'Cushing syndrome'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05215', 'Prostate cancer'), ('hsa05222', 'Small cell lung cancer'), ('hsa05226', 'Gastric cancer')]"
836,['(RefSeq) caspase 3'],4q35.1,"[('hsa01524', 'Platinum drug resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04115', 'p53 signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04215', 'Apoptosis - multiple species'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa04726', 'Serotonergic synapse'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05010', 'Alzheimer disease'), ('hsa05012', 'Parkinson disease'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05016', 'Huntington disease'), ('hsa05020', 'Prion disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05120', 'Epithelial cell signaling in Helicobacter pylori infection'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05132', 'Salmonella infection'), ('hsa05133', 'Pertussis'), ('hsa05134', 'Legionellosis'), ('hsa05145', 'Toxoplasmosis'), ('hsa05146', 'Amoebiasis'), ('hsa05152', 'Tuberculosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05210', 'Colorectal cancer'), ('hsa05222', 'Small cell lung cancer'), ('hsa05416', 'Viral myocarditis'), ('hsa05417', 'Lipid and atherosclerosis')]"
7419,['(RefSeq) voltage dependent anion channel 3'],8p11.21,"[('hsa04020', 'Calcium signaling pathway'), ('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04216', 'Ferroptosis'), ('hsa04217', 'Necroptosis'), ('hsa04218', 'Cellular senescence'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04979', 'Cholesterol metabolism'), ('hsa05010', 'Alzheimer disease'), ('hsa05012', 'Parkinson disease'), ('hsa05016', 'Huntington disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05161', 'Hepatitis B'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05415', 'Diabetic cardiomyopathy')]"
3265,"['(RefSeq) HRas proto-oncogene, GTPase']",11p15.5,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04137', 'Mitophagy - animal'), ('hsa04140', 'Autophagy - animal'), ('hsa04144', 'Endocytosis'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04371', 'Apelin signaling pathway'), ('hsa04510', 'Focal adhesion'), ('hsa04540', 'Gap junction'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04714', 'Thermogenesis'), ('hsa04720', 'Long-term potentiation'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04726', 'Serotonergic synapse'), ('hsa04730', 'Long-term depression'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04912', 'GnRH signaling pathway'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04921', 'Oxytocin signaling pathway'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05010', 'Alzheimer disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05034', 'Alcoholism'), ('hsa05132', 'Salmonella infection'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05216', 'Thyroid cancer'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05417', 'Lipid and atherosclerosis')]"
3845,"['(RefSeq) KRAS proto-oncogene, GTPase']",12p12.1,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04137', 'Mitophagy - animal'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04371', 'Apelin signaling pathway'), ('hsa04540', 'Gap junction'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04714', 'Thermogenesis'), ('hsa04720', 'Long-term potentiation'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04726', 'Serotonergic synapse'), ('hsa04730', 'Long-term depression'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04912', 'GnRH signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04921', 'Oxytocin signaling pathway'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05034', 'Alcoholism'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05216', 'Thyroid cancer'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05417', 'Lipid and atherosclerosis')]"
4893,"['(RefSeq) NRAS proto-oncogene, GTPase']",1p13.2,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04137', 'Mitophagy - animal'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04371', 'Apelin signaling pathway'), ('hsa04540', 'Gap junction'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04714', 'Thermogenesis'), ('hsa04720', 'Long-term potentiation'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04726', 'Serotonergic synapse'), ('hsa04730', 'Long-term depression'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04912', 'GnRH signaling pathway'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04921', 'Oxytocin signaling pathway'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05010', 'Alzheimer disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05034', 'Alcoholism'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05216', 'Thyroid cancer'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05417', 'Lipid and atherosclerosis')]"
10971,['(RefSeq) tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta'],2p25.1,"[('hsa04110', 'Cell cycle'), ('hsa04114', 'Oocyte meiosis'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04390', 'Hippo signaling pathway'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05203', 'Viral carcinogenesis')]"
7529,['(RefSeq) tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta'],20q13.12,"[('hsa04110', 'Cell cycle'), ('hsa04114', 'Oocyte meiosis'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04390', 'Hippo signaling pathway'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05203', 'Viral carcinogenesis')]"
7531,['(RefSeq) tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon'],17p13.3,"[('hsa04110', 'Cell cycle'), ('hsa04114', 'Oocyte meiosis'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04390', 'Hippo signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa05160', 'Hepatitis C'), ('hsa05203', 'Viral carcinogenesis')]"
7532,['(RefSeq) tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma'],7q11.23,"[('hsa04110', 'Cell cycle'), ('hsa04114', 'Oocyte meiosis'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04390', 'Hippo signaling pathway'), ('hsa05160', 'Hepatitis C'), ('hsa05203', 'Viral carcinogenesis')]"
7533,['(RefSeq) tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta'],22q12.3,"[('hsa04110', 'Cell cycle'), ('hsa04114', 'Oocyte meiosis'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04390', 'Hippo signaling pathway'), ('hsa05160', 'Hepatitis C'), ('hsa05203', 'Viral carcinogenesis')]"
7534,['(RefSeq) tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta'],8q22.3,"[('hsa04110', 'Cell cycle'), ('hsa04114', 'Oocyte meiosis'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04390', 'Hippo signaling pathway'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05203', 'Viral carcinogenesis')]"
6502,['(RefSeq) S-phase kinase associated protein 2'],5p13.2,"[('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04120', 'Ubiquitin mediated proteolysis'), ('hsa04150', 'mTOR signaling pathway'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05222', 'Small cell lung cancer')]"
11317,['(RefSeq) recombination signal binding protein for immunoglobulin kappa J region like'],20q13.12,"[('hsa04330', 'Notch signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05203', 'Viral carcinogenesis')]"
3516,['(RefSeq) recombination signal binding protein for immunoglobulin kappa J region'],4p15.2,"[('hsa04330', 'Notch signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05203', 'Viral carcinogenesis')]"
22938,['(RefSeq) SNW domain containing 1'],14q24.3,"[('hsa03040', 'Spliceosome'), ('hsa04330', 'Notch signaling pathway'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05203', 'Viral carcinogenesis')]"
2965,['(RefSeq) general transcription factor IIH subunit 1'],11p15.1,"[('hsa03022', 'Basal transcription factors'), ('hsa03420', 'Nucleotide excision repair'), ('hsa05203', 'Viral carcinogenesis')]"
2966,['(RefSeq) general transcription factor IIH subunit 2'],5q13.2,"[('hsa03022', 'Basal transcription factors'), ('hsa03420', 'Nucleotide excision repair'), ('hsa05203', 'Viral carcinogenesis')]"
2967,['(RefSeq) general transcription factor IIH subunit 3'],12q24.31,"[('hsa03022', 'Basal transcription factors'), ('hsa03420', 'Nucleotide excision repair'), ('hsa05203', 'Viral carcinogenesis')]"
2968,['(RefSeq) general transcription factor IIH subunit 4'],6p21.33,"[('hsa03022', 'Basal transcription factors'), ('hsa03420', 'Nucleotide excision repair'), ('hsa05203', 'Viral carcinogenesis')]"
728340,['(RefSeq) GTF2H2 family member C'],5q13.2,"[('hsa03022', 'Basal transcription factors'), ('hsa03420', 'Nucleotide excision repair'), ('hsa05203', 'Viral carcinogenesis')]"
730394,"['(RefSeq) GTF2H2 family member C, copy 2']",5q13.2,"[('hsa03022', 'Basal transcription factors'), ('hsa03420', 'Nucleotide excision repair'), ('hsa05203', 'Viral carcinogenesis')]"
2960,['(RefSeq) general transcription factor IIE subunit 1'],3q13.33,"[('hsa03022', 'Basal transcription factors'), ('hsa05203', 'Viral carcinogenesis')]"
2961,['(RefSeq) general transcription factor IIE subunit 2'],8p12,"[('hsa03022', 'Basal transcription factors'), ('hsa05203', 'Viral carcinogenesis')]"
27044,['(RefSeq) staphylococcal nuclease and tudor domain containing 1'],7q32.1,"[('hsa05203', 'Viral carcinogenesis')]"
1387,['(RefSeq) CREB binding protein'],16p13.3,"[('hsa04024', 'cAMP signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04330', 'Notch signaling pathway'), ('hsa04350', 'TGF-beta signaling pathway'), ('hsa04520', 'Adherens junction'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04720', 'Long-term potentiation'), ('hsa04916', 'Melanogenesis'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05016', 'Huntington disease'), ('hsa05152', 'Tuberculosis'), ('hsa05161', 'Hepatitis B'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05215', 'Prostate cancer')]"
2033,['(RefSeq) E1A binding protein p300'],22q13.2,"[('hsa04024', 'cAMP signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04330', 'Notch signaling pathway'), ('hsa04350', 'TGF-beta signaling pathway'), ('hsa04520', 'Adherens junction'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04720', 'Long-term potentiation'), ('hsa04916', 'Melanogenesis'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05016', 'Huntington disease'), ('hsa05152', 'Tuberculosis'), ('hsa05161', 'Hepatitis B'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05215', 'Prostate cancer')]"
2959,['(RefSeq) general transcription factor IIB'],1p22.2,"[('hsa03022', 'Basal transcription factors'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05203', 'Viral carcinogenesis')]"
7157,['(RefSeq) tumor protein p53'],17p13.1,"[('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04137', 'Mitophagy - animal'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04216', 'Ferroptosis'), ('hsa04218', 'Cellular senescence'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa05012', 'Parkinson disease'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05016', 'Huntington disease'), ('hsa05131', 'Shigellosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05210', 'Colorectal cancer'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05216', 'Thyroid cancer'), ('hsa05217', 'Basal cell carcinoma'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
245972,['(RefSeq) ATPase H+ transporting V0 subunit d2'],8q21.3,"[('hsa00190', 'Oxidative phosphorylation'), ('hsa01100', 'Metabolic pathways'), ('hsa04142', 'Lysosome'), ('hsa04145', 'Phagosome'), ('hsa04721', 'Synaptic vesicle cycle'), ('hsa04966', 'Collecting duct acid secretion'), ('hsa05110', 'Vibrio cholerae infection'), ('hsa05120', 'Epithelial cell signaling in Helicobacter pylori infection'), ('hsa05152', 'Tuberculosis'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05323', 'Rheumatoid arthritis')]"
9114,['(RefSeq) ATPase H+ transporting V0 subunit d1'],16q22.1,"[('hsa00190', 'Oxidative phosphorylation'), ('hsa01100', 'Metabolic pathways'), ('hsa04142', 'Lysosome'), ('hsa04145', 'Phagosome'), ('hsa04721', 'Synaptic vesicle cycle'), ('hsa04966', 'Collecting duct acid secretion'), ('hsa05110', 'Vibrio cholerae infection'), ('hsa05120', 'Epithelial cell signaling in Helicobacter pylori infection'), ('hsa05152', 'Tuberculosis'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05323', 'Rheumatoid arthritis')]"
9093,['(RefSeq) DnaJ heat shock protein family (Hsp40) member A3'],16p13.3,"[('hsa05203', 'Viral carcinogenesis')]"
1026,['(RefSeq) cyclin dependent kinase inhibitor 1A'],6p21.2,"[('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04921', 'Oxytocin signaling pathway'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04934', 'Cushing syndrome'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05216', 'Thyroid cancer'), ('hsa05217', 'Basal cell carcinoma'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer')]"
1027,['(RefSeq) cyclin dependent kinase inhibitor 1B'],12p13.1,"[('hsa01522', 'Endocrine resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04934', 'Cushing syndrome'), ('hsa05162', 'Measles'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05215', 'Prostate cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05226', 'Gastric cancer')]"
1387,['(RefSeq) CREB binding protein'],16p13.3,"[('hsa04024', 'cAMP signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04330', 'Notch signaling pathway'), ('hsa04350', 'TGF-beta signaling pathway'), ('hsa04520', 'Adherens junction'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04720', 'Long-term potentiation'), ('hsa04916', 'Melanogenesis'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05016', 'Huntington disease'), ('hsa05152', 'Tuberculosis'), ('hsa05161', 'Hepatitis B'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05215', 'Prostate cancer')]"
2033,['(RefSeq) E1A binding protein p300'],22q13.2,"[('hsa04024', 'cAMP signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04330', 'Notch signaling pathway'), ('hsa04350', 'TGF-beta signaling pathway'), ('hsa04520', 'Adherens junction'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04720', 'Long-term potentiation'), ('hsa04916', 'Melanogenesis'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05016', 'Huntington disease'), ('hsa05152', 'Tuberculosis'), ('hsa05161', 'Hepatitis B'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05215', 'Prostate cancer')]"
5315,['(RefSeq) pyruvate kinase M1/2'],15q23,"[('hsa00010', 'Glycolysis / Gluconeogenesis'), ('hsa00620', 'Pyruvate metabolism'), ('hsa01100', 'Metabolic pathways'), ('hsa01200', 'Carbon metabolism'), ('hsa01230', 'Biosynthesis of amino acids'), ('hsa01240', 'Biosynthesis of cofactors'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05230', 'Central carbon metabolism in cancer')]"
10013,['(RefSeq) histone deacetylase 6'],Xp11.23,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis')]"
10014,['(RefSeq) histone deacetylase 5'],17q21.31,"[('hsa04371', 'Apelin signaling pathway'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer')]"
3065,['(RefSeq) histone deacetylase 1'],1p35.2-p35.1,"[('hsa04110', 'Cell cycle'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04330', 'Notch signaling pathway'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa05016', 'Huntington disease'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05220', 'Chronic myeloid leukemia')]"
3066,['(RefSeq) histone deacetylase 2'],6q21,"[('hsa04110', 'Cell cycle'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04330', 'Notch signaling pathway'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa05016', 'Huntington disease'), ('hsa05031', 'Amphetamine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05220', 'Chronic myeloid leukemia')]"
51564,['(RefSeq) histone deacetylase 7'],12q13.11,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis')]"
55869,['(RefSeq) histone deacetylase 8'],Xq13.1,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis')]"
79885,['(RefSeq) histone deacetylase 11'],3p25.1,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis')]"
83933,['(RefSeq) histone deacetylase 10'],22q13.33,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis')]"
8841,['(RefSeq) histone deacetylase 3'],5q31.3,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis')]"
9734,['(RefSeq) histone deacetylase 9'],7p21.1,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis')]"
1387,['(RefSeq) CREB binding protein'],16p13.3,"[('hsa04024', 'cAMP signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04330', 'Notch signaling pathway'), ('hsa04350', 'TGF-beta signaling pathway'), ('hsa04520', 'Adherens junction'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04720', 'Long-term potentiation'), ('hsa04916', 'Melanogenesis'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05016', 'Huntington disease'), ('hsa05152', 'Tuberculosis'), ('hsa05161', 'Hepatitis B'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05215', 'Prostate cancer')]"
2033,['(RefSeq) E1A binding protein p300'],22q13.2,"[('hsa04024', 'cAMP signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04330', 'Notch signaling pathway'), ('hsa04350', 'TGF-beta signaling pathway'), ('hsa04520', 'Adherens junction'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04720', 'Long-term potentiation'), ('hsa04916', 'Melanogenesis'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05016', 'Huntington disease'), ('hsa05152', 'Tuberculosis'), ('hsa05161', 'Hepatitis B'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05215', 'Prostate cancer')]"
4790,['(RefSeq) nuclear factor kappa B subunit 1'],4q24,"[('hsa01523', 'Antifolate resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa04623', 'Cytosolic DNA-sensing pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa04659', 'Th17 cell differentiation'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04920', 'Adipocytokine signaling pathway'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05010', 'Alzheimer disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05030', 'Cocaine addiction'), ('hsa05120', 'Epithelial cell signaling in Helicobacter pylori infection'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05133', 'Pertussis'), ('hsa05134', 'Legionellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05140', 'Leishmaniasis'), ('hsa05142', 'Chagas disease'), ('hsa05145', 'Toxoplasmosis'), ('hsa05146', 'Amoebiasis'), ('hsa05152', 'Tuberculosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05212', 'Pancreatic cancer'), ('hsa05215', 'Prostate cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05321', 'Inflammatory bowel disease'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
4791,['(RefSeq) nuclear factor kappa B subunit 2'],10q24.32,"[('hsa04010', 'MAPK signaling pathway'), ('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa05134', 'Legionellosis'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05224', 'Breast cancer')]"
5966,"['(RefSeq) REL proto-oncogene, NF-kB subunit']",2p16.1,"[('hsa04014', 'Ras signaling pathway'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis')]"
5970,"['(RefSeq) RELA proto-oncogene, NF-kB subunit']",11q13.1,"[('hsa01523', 'Antifolate resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04137', 'Mitophagy - animal'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa04623', 'Cytosolic DNA-sensing pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa04659', 'Th17 cell differentiation'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04920', 'Adipocytokine signaling pathway'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05010', 'Alzheimer disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05030', 'Cocaine addiction'), ('hsa05120', 'Epithelial cell signaling in Helicobacter pylori infection'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05133', 'Pertussis'), ('hsa05134', 'Legionellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05140', 'Leishmaniasis'), ('hsa05142', 'Chagas disease'), ('hsa05145', 'Toxoplasmosis'), ('hsa05146', 'Amoebiasis'), ('hsa05152', 'Tuberculosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05212', 'Pancreatic cancer'), ('hsa05215', 'Prostate cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05321', 'Inflammatory bowel disease'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
595,['(RefSeq) cyclin D1'],11q13.3,"[('hsa01522', 'Endocrine resistance'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04340', 'Hedgehog signaling pathway'), ('hsa04371', 'Apelin signaling pathway'), ('hsa04390', 'Hippo signaling pathway'), ('hsa04510', 'Focal adhesion'), ('hsa04530', 'Tight junction'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04921', 'Oxytocin signaling pathway'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04934', 'Cushing syndrome'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05160', 'Hepatitis C'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05210', 'Colorectal cancer'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05216', 'Thyroid cancer'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05416', 'Viral myocarditis')]"
894,['(RefSeq) cyclin D2'],12p13.32,"[('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04340', 'Hedgehog signaling pathway'), ('hsa04390', 'Hippo signaling pathway'), ('hsa04510', 'Focal adhesion'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa05162', 'Measles'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer')]"
896,['(RefSeq) cyclin D3'],6p21.1,"[('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04390', 'Hippo signaling pathway'), ('hsa04510', 'Focal adhesion'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa05162', 'Measles'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation')]"
5922,['(RefSeq) RAS p21 protein activator 2'],3q23,"[('hsa04010', 'MAPK signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa05203', 'Viral carcinogenesis')]"
998,['(RefSeq) cell division cycle 42'],1p36.12,"[('hsa04010', 'MAPK signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04144', 'Endocytosis'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04510', 'Focal adhesion'), ('hsa04520', 'Adherens junction'), ('hsa04530', 'Tight junction'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04912', 'GnRH signaling pathway'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05120', 'Epithelial cell signaling in Helicobacter pylori infection'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05135', 'Yersinia infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05417', 'Lipid and atherosclerosis')]"
5879,['(RefSeq) Rac family small GTPase 1'],7p22.1,"[('hsa04010', 'MAPK signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04145', 'Phagosome'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04520', 'Adherens junction'), ('hsa04530', 'Tight junction'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04972', 'Pancreatic secretion'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05020', 'Prion disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05120', 'Epithelial cell signaling in Helicobacter pylori infection'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05135', 'Yersinia infection'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05416', 'Viral myocarditis'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
387,['(RefSeq) ras homolog family member A'],3p21.31,"[('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04022', 'cGMP-PKG signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04144', 'Endocytosis'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04270', 'Vascular smooth muscle contraction'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04350', 'TGF-beta signaling pathway'), ('hsa04360', 'Axon guidance'), ('hsa04510', 'Focal adhesion'), ('hsa04520', 'Adherens junction'), ('hsa04530', 'Tight junction'), ('hsa04611', 'Platelet activation'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04921', 'Oxytocin signaling pathway'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04972', 'Pancreatic secretion'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05133', 'Pertussis'), ('hsa05135', 'Yersinia infection'), ('hsa05152', 'Tuberculosis'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05210', 'Colorectal cancer'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
2934,['(RefSeq) gelsolin'],9q33.2,"[('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa05203', 'Viral carcinogenesis')]"
85477,['(RefSeq) scinderin'],7p21.3,"[('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa05203', 'Viral carcinogenesis')]"
81,['(RefSeq) actinin alpha 4'],19q13.2,"[('hsa04510', 'Focal adhesion'), ('hsa04520', 'Adherens junction'), ('hsa04530', 'Tight junction'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa05131', 'Shigellosis'), ('hsa05146', 'Amoebiasis'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
87,['(RefSeq) actinin alpha 1'],14q24.1; 14q22-q24,"[('hsa04510', 'Focal adhesion'), ('hsa04520', 'Adherens junction'), ('hsa04530', 'Tight junction'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa05131', 'Shigellosis'), ('hsa05146', 'Amoebiasis'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
4792,['(RefSeq) NFKB inhibitor alpha'],14q13.2,"[('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa04623', 'Cytosolic DNA-sensing pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa04659', 'Th17 cell differentiation'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04920', 'Adipocytokine signaling pathway'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04931', 'Insulin resistance'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05120', 'Epithelial cell signaling in Helicobacter pylori infection'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05134', 'Legionellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05140', 'Leishmaniasis'), ('hsa05142', 'Chagas disease'), ('hsa05145', 'Toxoplasmosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05215', 'Prostate cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05417', 'Lipid and atherosclerosis')]"
387332,['(RefSeq) TATA-box binding protein like 2'],14q22.3,"[('hsa03022', 'Basal transcription factors'), ('hsa05016', 'Huntington disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
6908,['(RefSeq) TATA-box binding protein'],6q27,"[('hsa03022', 'Basal transcription factors'), ('hsa05016', 'Huntington disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
9519,['(RefSeq) TATA-box binding protein like 1'],6q23.2,"[('hsa03022', 'Basal transcription factors'), ('hsa05016', 'Huntington disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
11036,['(RefSeq) general transcription factor IIA subunit 1 like'],2p16.3,"[('hsa03022', 'Basal transcription factors'), ('hsa05203', 'Viral carcinogenesis')]"
2957,['(RefSeq) general transcription factor IIA subunit 1'],14q31.1,"[('hsa03022', 'Basal transcription factors'), ('hsa05203', 'Viral carcinogenesis')]"
2958,['(RefSeq) general transcription factor IIA subunit 2'],15q22.2,"[('hsa03022', 'Basal transcription factors'), ('hsa05203', 'Viral carcinogenesis')]"
991,['(RefSeq) cell division cycle 20'],1p34.2,"[('hsa04110', 'Cell cycle'), ('hsa04114', 'Oocyte meiosis'), ('hsa04120', 'Ubiquitin mediated proteolysis'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
1111,['(RefSeq) checkpoint kinase 1'],11q24.2,"[('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
1021,['(RefSeq) cyclin dependent kinase 6'],7q21.2,"[('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04934', 'Cushing syndrome'), ('hsa05160', 'Hepatitis C'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05212', 'Pancreatic cancer'), ('hsa05214', 'Glioma'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma')]"
5290,"['(RefSeq) phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha']",3q26.32,"[('hsa00562', 'Inositol phosphate metabolism'), ('hsa01100', 'Metabolic pathways'), ('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
5291,"['(RefSeq) phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta']",3q22.3,"[('hsa00562', 'Inositol phosphate metabolism'), ('hsa01100', 'Metabolic pathways'), ('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
5293,"['(RefSeq) phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta']",1p36.22,"[('hsa00562', 'Inositol phosphate metabolism'), ('hsa01100', 'Metabolic pathways'), ('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
5295,['(RefSeq) phosphoinositide-3-kinase regulatory subunit 1'],5q13.1,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
5296,['(RefSeq) phosphoinositide-3-kinase regulatory subunit 2'],19p13.11,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
8503,['(RefSeq) phosphoinositide-3-kinase regulatory subunit 3'],1p34.1,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
1387,['(RefSeq) CREB binding protein'],16p13.3,"[('hsa04024', 'cAMP signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04330', 'Notch signaling pathway'), ('hsa04350', 'TGF-beta signaling pathway'), ('hsa04520', 'Adherens junction'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04720', 'Long-term potentiation'), ('hsa04916', 'Melanogenesis'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05016', 'Huntington disease'), ('hsa05152', 'Tuberculosis'), ('hsa05161', 'Hepatitis B'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05215', 'Prostate cancer')]"
2033,['(RefSeq) E1A binding protein p300'],22q13.2,"[('hsa04024', 'cAMP signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04330', 'Notch signaling pathway'), ('hsa04350', 'TGF-beta signaling pathway'), ('hsa04520', 'Adherens junction'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04720', 'Long-term potentiation'), ('hsa04916', 'Melanogenesis'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05016', 'Huntington disease'), ('hsa05152', 'Tuberculosis'), ('hsa05161', 'Hepatitis B'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05215', 'Prostate cancer')]"
3665,['(RefSeq) interferon regulatory factor 7'],11p15.5,"[('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa04623', 'Cytosolic DNA-sensing pathway'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05164', 'Influenza A'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05417', 'Lipid and atherosclerosis')]"
3572,['(RefSeq) interleukin 6 cytokine family signal transducer'],5q11.2,"[('hsa04060', 'Cytokine-cytokine receptor interaction'), ('hsa04061', 'Viral protein interaction with cytokine and cytokine receptor'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04659', 'Th17 cell differentiation'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis')]"
9261,['(RefSeq) MAPK activated protein kinase 2'],1q32.1,"[('hsa04010', 'MAPK signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05203', 'Viral carcinogenesis')]"
718,['(RefSeq) complement C3'],19p13.3,"[('hsa04080', 'Neuroactive ligand-receptor interaction'), ('hsa04145', 'Phagosome'), ('hsa04610', 'Complement and coagulation cascades'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05131', 'Shigellosis'), ('hsa05133', 'Pertussis'), ('hsa05134', 'Legionellosis'), ('hsa05140', 'Leishmaniasis'), ('hsa05142', 'Chagas disease'), ('hsa05150', 'Staphylococcus aureus infection'), ('hsa05152', 'Tuberculosis'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
3105,"['(RefSeq) major histocompatibility complex, class I, A']",6p22.1,"[('hsa04144', 'Endocytosis'), ('hsa04145', 'Phagosome'), ('hsa04218', 'Cellular senescence'), ('hsa04514', 'Cell adhesion molecules'), ('hsa04612', 'Antigen processing and presentation'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04940', 'Type I diabetes mellitus'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05320', 'Autoimmune thyroid disease'), ('hsa05330', 'Allograft rejection'), ('hsa05332', 'Graft-versus-host disease'), ('hsa05416', 'Viral myocarditis')]"
3106,"['(RefSeq) major histocompatibility complex, class I, B']",6p21.33,"[('hsa04144', 'Endocytosis'), ('hsa04145', 'Phagosome'), ('hsa04218', 'Cellular senescence'), ('hsa04514', 'Cell adhesion molecules'), ('hsa04612', 'Antigen processing and presentation'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04940', 'Type I diabetes mellitus'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05320', 'Autoimmune thyroid disease'), ('hsa05330', 'Allograft rejection'), ('hsa05332', 'Graft-versus-host disease'), ('hsa05416', 'Viral myocarditis')]"
3107,"['(RefSeq) major histocompatibility complex, class I, C']",6p21.33,"[('hsa04144', 'Endocytosis'), ('hsa04145', 'Phagosome'), ('hsa04218', 'Cellular senescence'), ('hsa04514', 'Cell adhesion molecules'), ('hsa04612', 'Antigen processing and presentation'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04940', 'Type I diabetes mellitus'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05320', 'Autoimmune thyroid disease'), ('hsa05330', 'Allograft rejection'), ('hsa05332', 'Graft-versus-host disease'), ('hsa05416', 'Viral myocarditis')]"
3133,"['(RefSeq) major histocompatibility complex, class I, E']",6p22.1,"[('hsa04144', 'Endocytosis'), ('hsa04145', 'Phagosome'), ('hsa04218', 'Cellular senescence'), ('hsa04514', 'Cell adhesion molecules'), ('hsa04612', 'Antigen processing and presentation'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04940', 'Type I diabetes mellitus'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05320', 'Autoimmune thyroid disease'), ('hsa05330', 'Allograft rejection'), ('hsa05332', 'Graft-versus-host disease'), ('hsa05416', 'Viral myocarditis')]"
3134,"['(RefSeq) major histocompatibility complex, class I, F']",6p22.1,"[('hsa04144', 'Endocytosis'), ('hsa04145', 'Phagosome'), ('hsa04218', 'Cellular senescence'), ('hsa04514', 'Cell adhesion molecules'), ('hsa04612', 'Antigen processing and presentation'), ('hsa04940', 'Type I diabetes mellitus'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05320', 'Autoimmune thyroid disease'), ('hsa05330', 'Allograft rejection'), ('hsa05332', 'Graft-versus-host disease'), ('hsa05416', 'Viral myocarditis')]"
3135,"['(RefSeq) major histocompatibility complex, class I, G']",6p22.1,"[('hsa04144', 'Endocytosis'), ('hsa04145', 'Phagosome'), ('hsa04218', 'Cellular senescence'), ('hsa04514', 'Cell adhesion molecules'), ('hsa04612', 'Antigen processing and presentation'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04940', 'Type I diabetes mellitus'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05320', 'Autoimmune thyroid disease'), ('hsa05330', 'Allograft rejection'), ('hsa05332', 'Graft-versus-host disease'), ('hsa05416', 'Viral myocarditis')]"
1237,['(RefSeq) C-C motif chemokine receptor 8'],3p22.1,"[('hsa04060', 'Cytokine-cytokine receptor interaction'), ('hsa04061', 'Viral protein interaction with cytokine and cytokine receptor'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05203', 'Viral carcinogenesis')]"
4055,['(RefSeq) lymphotoxin beta receptor'],12p13.31,"[('hsa04060', 'Cytokine-cytokine receptor interaction'), ('hsa04061', 'Viral protein interaction with cytokine and cytokine receptor'), ('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04672', 'Intestinal immune network for IgA production'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
3190,['(RefSeq) heterogeneous nuclear ribonucleoprotein K'],9q21.32,"[('hsa03040', 'Spliceosome'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer')]"
1654,['(RefSeq) DEAD-box helicase 3 X-linked'],Xp11.4,"[('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa05161', 'Hepatitis B'), ('hsa05203', 'Viral carcinogenesis')]"
7531,['(RefSeq) tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon'],17p13.3,"[('hsa04110', 'Cell cycle'), ('hsa04114', 'Oocyte meiosis'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04390', 'Hippo signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa05160', 'Hepatitis C'), ('hsa05203', 'Viral carcinogenesis')]"
5610,['(RefSeq) eukaryotic translation initiation factor 2 alpha kinase 2'],2p22.2,"[('hsa04141', 'Protein processing in endoplasmic reticulum'), ('hsa04217', 'Necroptosis'), ('hsa05010', 'Alzheimer disease'), ('hsa05160', 'Hepatitis C'), ('hsa05162', 'Measles'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05203', 'Viral carcinogenesis')]"
1026,['(RefSeq) cyclin dependent kinase inhibitor 1A'],6p21.2,"[('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04921', 'Oxytocin signaling pathway'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04934', 'Cushing syndrome'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05216', 'Thyroid cancer'), ('hsa05217', 'Basal cell carcinoma'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer')]"
5566,['(RefSeq) protein kinase cAMP-activated catalytic subunit alpha'],19p13.12,"[('hsa01522', 'Endocrine resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04020', 'Calcium signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04114', 'Oocyte meiosis'), ('hsa04140', 'Autophagy - animal'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04270', 'Vascular smooth muscle contraction'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04340', 'Hedgehog signaling pathway'), ('hsa04371', 'Apelin signaling pathway'), ('hsa04530', 'Tight junction'), ('hsa04540', 'Gap junction'), ('hsa04611', 'Platelet activation'), ('hsa04713', 'Circadian entrainment'), ('hsa04714', 'Thermogenesis'), ('hsa04720', 'Long-term potentiation'), ('hsa04723', 'Retrograde endocannabinoid signaling'), ('hsa04724', 'Glutamatergic synapse'), ('hsa04725', 'Cholinergic synapse'), ('hsa04726', 'Serotonergic synapse'), ('hsa04727', 'GABAergic synapse'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04740', 'Olfactory transduction'), ('hsa04742', 'Taste transduction'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04911', 'Insulin secretion'), ('hsa04912', 'GnRH signaling pathway'), ('hsa04913', 'Ovarian steroidogenesis'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04921', 'Oxytocin signaling pathway'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04924', 'Renin secretion'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04961', 'Endocrine and other factor-regulated calcium reabsorption'), ('hsa04962', 'Vasopressin-regulated water reabsorption'), ('hsa04970', 'Salivary secretion'), ('hsa04971', 'Gastric acid secretion'), ('hsa04976', 'Bile secretion'), ('hsa05012', 'Parkinson disease'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05032', 'Morphine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05110', 'Vibrio cholerae infection'), ('hsa05146', 'Amoebiasis'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05414', 'Dilated cardiomyopathy')]"
5567,['(RefSeq) protein kinase cAMP-activated catalytic subunit beta'],1p31.1,"[('hsa01522', 'Endocrine resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04020', 'Calcium signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04114', 'Oocyte meiosis'), ('hsa04140', 'Autophagy - animal'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04270', 'Vascular smooth muscle contraction'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04340', 'Hedgehog signaling pathway'), ('hsa04371', 'Apelin signaling pathway'), ('hsa04530', 'Tight junction'), ('hsa04540', 'Gap junction'), ('hsa04611', 'Platelet activation'), ('hsa04713', 'Circadian entrainment'), ('hsa04714', 'Thermogenesis'), ('hsa04720', 'Long-term potentiation'), ('hsa04723', 'Retrograde endocannabinoid signaling'), ('hsa04724', 'Glutamatergic synapse'), ('hsa04725', 'Cholinergic synapse'), ('hsa04726', 'Serotonergic synapse'), ('hsa04727', 'GABAergic synapse'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04740', 'Olfactory transduction'), ('hsa04742', 'Taste transduction'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04911', 'Insulin secretion'), ('hsa04912', 'GnRH signaling pathway'), ('hsa04913', 'Ovarian steroidogenesis'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04921', 'Oxytocin signaling pathway'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04924', 'Renin secretion'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04961', 'Endocrine and other factor-regulated calcium reabsorption'), ('hsa04962', 'Vasopressin-regulated water reabsorption'), ('hsa04970', 'Salivary secretion'), ('hsa04971', 'Gastric acid secretion'), ('hsa04976', 'Bile secretion'), ('hsa05012', 'Parkinson disease'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05032', 'Morphine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05110', 'Vibrio cholerae infection'), ('hsa05146', 'Amoebiasis'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05414', 'Dilated cardiomyopathy')]"
5568,['(RefSeq) protein kinase cAMP-activated catalytic subunit gamma'],9q21.11,"[('hsa01522', 'Endocrine resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04020', 'Calcium signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04114', 'Oocyte meiosis'), ('hsa04140', 'Autophagy - animal'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04261', 'Adrenergic signaling in cardiomyocytes'), ('hsa04270', 'Vascular smooth muscle contraction'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04340', 'Hedgehog signaling pathway'), ('hsa04371', 'Apelin signaling pathway'), ('hsa04530', 'Tight junction'), ('hsa04540', 'Gap junction'), ('hsa04611', 'Platelet activation'), ('hsa04713', 'Circadian entrainment'), ('hsa04714', 'Thermogenesis'), ('hsa04720', 'Long-term potentiation'), ('hsa04723', 'Retrograde endocannabinoid signaling'), ('hsa04724', 'Glutamatergic synapse'), ('hsa04725', 'Cholinergic synapse'), ('hsa04726', 'Serotonergic synapse'), ('hsa04727', 'GABAergic synapse'), ('hsa04728', 'Dopaminergic synapse'), ('hsa04740', 'Olfactory transduction'), ('hsa04742', 'Taste transduction'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04911', 'Insulin secretion'), ('hsa04912', 'GnRH signaling pathway'), ('hsa04913', 'Ovarian steroidogenesis'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04916', 'Melanogenesis'), ('hsa04918', 'Thyroid hormone synthesis'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04921', 'Oxytocin signaling pathway'), ('hsa04922', 'Glucagon signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04924', 'Renin secretion'), ('hsa04925', 'Aldosterone synthesis and secretion'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04927', 'Cortisol synthesis and secretion'), ('hsa04928', 'Parathyroid hormone synthesis, secretion and action'), ('hsa04934', 'Cushing syndrome'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04961', 'Endocrine and other factor-regulated calcium reabsorption'), ('hsa04962', 'Vasopressin-regulated water reabsorption'), ('hsa04970', 'Salivary secretion'), ('hsa04971', 'Gastric acid secretion'), ('hsa04976', 'Bile secretion'), ('hsa05012', 'Parkinson disease'), ('hsa05020', 'Prion disease'), ('hsa05030', 'Cocaine addiction'), ('hsa05031', 'Amphetamine addiction'), ('hsa05032', 'Morphine addiction'), ('hsa05034', 'Alcoholism'), ('hsa05110', 'Vibrio cholerae infection'), ('hsa05146', 'Amoebiasis'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05414', 'Dilated cardiomyopathy')]"
7157,['(RefSeq) tumor protein p53'],17p13.1,"[('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04110', 'Cell cycle'), ('hsa04115', 'p53 signaling pathway'), ('hsa04137', 'Mitophagy - animal'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04216', 'Ferroptosis'), ('hsa04218', 'Cellular senescence'), ('hsa04310', 'Wnt signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa05012', 'Parkinson disease'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05016', 'Huntington disease'), ('hsa05131', 'Shigellosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05210', 'Colorectal cancer'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05216', 'Thyroid cancer'), ('hsa05217', 'Basal cell carcinoma'), ('hsa05218', 'Melanoma'), ('hsa05219', 'Bladder cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
581,"['(RefSeq) BCL2 associated X, apoptosis regulator']",19q13.33,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04115', 'p53 signaling pathway'), ('hsa04141', 'Protein processing in endoplasmic reticulum'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04215', 'Apoptosis - multiple species'), ('hsa04217', 'Necroptosis'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa05012', 'Parkinson disease'), ('hsa05014', 'Amyotrophic lateral sclerosis'), ('hsa05016', 'Huntington disease'), ('hsa05020', 'Prion disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05152', 'Tuberculosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05210', 'Colorectal cancer'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05216', 'Thyroid cancer'), ('hsa05217', 'Basal cell carcinoma'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05417', 'Lipid and atherosclerosis')]"
5610,['(RefSeq) eukaryotic translation initiation factor 2 alpha kinase 2'],2p22.2,"[('hsa04141', 'Protein processing in endoplasmic reticulum'), ('hsa04217', 'Necroptosis'), ('hsa05010', 'Alzheimer disease'), ('hsa05160', 'Hepatitis C'), ('hsa05162', 'Measles'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05203', 'Viral carcinogenesis')]"
2885,['(RefSeq) growth factor receptor bound protein 2'],17q25.1,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04540', 'Gap junction'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04714', 'Thermogenesis'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04912', 'GnRH signaling pathway'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa05034', 'Alcoholism'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05231', 'Choline metabolism in cancer')]"
5290,"['(RefSeq) phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha']",3q26.32,"[('hsa00562', 'Inositol phosphate metabolism'), ('hsa01100', 'Metabolic pathways'), ('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
5291,"['(RefSeq) phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta']",3q22.3,"[('hsa00562', 'Inositol phosphate metabolism'), ('hsa01100', 'Metabolic pathways'), ('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
5293,"['(RefSeq) phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta']",1p36.22,"[('hsa00562', 'Inositol phosphate metabolism'), ('hsa01100', 'Metabolic pathways'), ('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
5295,['(RefSeq) phosphoinositide-3-kinase regulatory subunit 1'],5q13.1,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
5296,['(RefSeq) phosphoinositide-3-kinase regulatory subunit 2'],19p13.11,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
8503,['(RefSeq) phosphoinositide-3-kinase regulatory subunit 3'],1p34.1,"[('hsa01521', 'EGFR tyrosine kinase inhibitor resistance'), ('hsa01522', 'Endocrine resistance'), ('hsa01524', 'Platinum drug resistance'), ('hsa04012', 'ErbB signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04015', 'Rap1 signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04068', 'FoxO signaling pathway'), ('hsa04070', 'Phosphatidylinositol signaling system'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04072', 'Phospholipase D signaling pathway'), ('hsa04140', 'Autophagy - animal'), ('hsa04150', 'mTOR signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04152', 'AMPK signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04213', 'Longevity regulating pathway - multiple species'), ('hsa04218', 'Cellular senescence'), ('hsa04360', 'Axon guidance'), ('hsa04370', 'VEGF signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04510', 'Focal adhesion'), ('hsa04550', 'Signaling pathways regulating pluripotency of stem cells'), ('hsa04611', 'Platelet activation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04630', 'JAK-STAT signaling pathway'), ('hsa04650', 'Natural killer cell mediated cytotoxicity'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04664', 'Fc epsilon RI signaling pathway'), ('hsa04666', 'Fc gamma R-mediated phagocytosis'), ('hsa04668', 'TNF signaling pathway'), ('hsa04670', 'Leukocyte transendothelial migration'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04725', 'Cholinergic synapse'), ('hsa04750', 'Inflammatory mediator regulation of TRP channels'), ('hsa04810', 'Regulation of actin cytoskeleton'), ('hsa04910', 'Insulin signaling pathway'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa04915', 'Estrogen signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04919', 'Thyroid hormone signaling pathway'), ('hsa04923', 'Regulation of lipolysis in adipocytes'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04929', 'GnRH secretion'), ('hsa04930', 'Type II diabetes mellitus'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04935', 'Growth hormone synthesis, secretion and action'), ('hsa04960', 'Aldosterone-regulated sodium reabsorption'), ('hsa04973', 'Carbohydrate digestion and absorption'), ('hsa05010', 'Alzheimer disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05020', 'Prion disease'), ('hsa05100', 'Bacterial invasion of epithelial cells'), ('hsa05131', 'Shigellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05142', 'Chagas disease'), ('hsa05146', 'Amoebiasis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05205', 'Proteoglycans in cancer'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05210', 'Colorectal cancer'), ('hsa05211', 'Renal cell carcinoma'), ('hsa05212', 'Pancreatic cancer'), ('hsa05213', 'Endometrial cancer'), ('hsa05214', 'Glioma'), ('hsa05215', 'Prostate cancer'), ('hsa05218', 'Melanoma'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05223', 'Non-small cell lung cancer'), ('hsa05224', 'Breast cancer'), ('hsa05225', 'Hepatocellular carcinoma'), ('hsa05226', 'Gastric cancer'), ('hsa05230', 'Central carbon metabolism in cancer'), ('hsa05231', 'Choline metabolism in cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
8717,['(RefSeq) TNFRSF1A associated via death domain'],16q22.1,"[('hsa04010', 'MAPK signaling pathway'), ('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04217', 'Necroptosis'), ('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa04920', 'Adipocytokine signaling pathway'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05152', 'Tuberculosis'), ('hsa05160', 'Hepatitis C'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
983,['(RefSeq) cyclin dependent kinase 1'],10q21.2,"[('hsa04110', 'Cell cycle'), ('hsa04114', 'Oocyte meiosis'), ('hsa04115', 'p53 signaling pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04540', 'Gap junction'), ('hsa04914', 'Progesterone-mediated oocyte maturation'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
387332,['(RefSeq) TATA-box binding protein like 2'],14q22.3,"[('hsa03022', 'Basal transcription factors'), ('hsa05016', 'Huntington disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
6908,['(RefSeq) TATA-box binding protein'],6q27,"[('hsa03022', 'Basal transcription factors'), ('hsa05016', 'Huntington disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
9519,['(RefSeq) TATA-box binding protein like 1'],6q23.2,"[('hsa03022', 'Basal transcription factors'), ('hsa05016', 'Huntington disease'), ('hsa05017', 'Spinocerebellar ataxia'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
6672,['(RefSeq) SP100 nuclear antigen'],2q37.1,"[('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05203', 'Viral carcinogenesis')]"
4790,['(RefSeq) nuclear factor kappa B subunit 1'],4q24,"[('hsa01523', 'Antifolate resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa04623', 'Cytosolic DNA-sensing pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa04659', 'Th17 cell differentiation'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04920', 'Adipocytokine signaling pathway'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05010', 'Alzheimer disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05030', 'Cocaine addiction'), ('hsa05120', 'Epithelial cell signaling in Helicobacter pylori infection'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05133', 'Pertussis'), ('hsa05134', 'Legionellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05140', 'Leishmaniasis'), ('hsa05142', 'Chagas disease'), ('hsa05145', 'Toxoplasmosis'), ('hsa05146', 'Amoebiasis'), ('hsa05152', 'Tuberculosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05206', 'MicroRNAs in cancer'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05212', 'Pancreatic cancer'), ('hsa05215', 'Prostate cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05321', 'Inflammatory bowel disease'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
4791,['(RefSeq) nuclear factor kappa B subunit 2'],10q24.32,"[('hsa04010', 'MAPK signaling pathway'), ('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa05134', 'Legionellosis'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05200', 'Pathways in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05224', 'Breast cancer')]"
5966,"['(RefSeq) REL proto-oncogene, NF-kB subunit']",2p16.1,"[('hsa04014', 'Ras signaling pathway'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis')]"
5970,"['(RefSeq) RELA proto-oncogene, NF-kB subunit']",11q13.1,"[('hsa01523', 'Antifolate resistance'), ('hsa04010', 'MAPK signaling pathway'), ('hsa04014', 'Ras signaling pathway'), ('hsa04024', 'cAMP signaling pathway'), ('hsa04062', 'Chemokine signaling pathway'), ('hsa04064', 'NF-kappa B signaling pathway'), ('hsa04066', 'HIF-1 signaling pathway'), ('hsa04071', 'Sphingolipid signaling pathway'), ('hsa04137', 'Mitophagy - animal'), ('hsa04151', 'PI3K-Akt signaling pathway'), ('hsa04210', 'Apoptosis'), ('hsa04211', 'Longevity regulating pathway'), ('hsa04218', 'Cellular senescence'), ('hsa04380', 'Osteoclast differentiation'), ('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa04620', 'Toll-like receptor signaling pathway'), ('hsa04621', 'NOD-like receptor signaling pathway'), ('hsa04622', 'RIG-I-like receptor signaling pathway'), ('hsa04623', 'Cytosolic DNA-sensing pathway'), ('hsa04625', 'C-type lectin receptor signaling pathway'), ('hsa04657', 'IL-17 signaling pathway'), ('hsa04658', 'Th1 and Th2 cell differentiation'), ('hsa04659', 'Th17 cell differentiation'), ('hsa04660', 'T cell receptor signaling pathway'), ('hsa04662', 'B cell receptor signaling pathway'), ('hsa04668', 'TNF signaling pathway'), ('hsa04722', 'Neurotrophin signaling pathway'), ('hsa04917', 'Prolactin signaling pathway'), ('hsa04920', 'Adipocytokine signaling pathway'), ('hsa04926', 'Relaxin signaling pathway'), ('hsa04931', 'Insulin resistance'), ('hsa04932', 'Non-alcoholic fatty liver disease'), ('hsa04933', 'AGE-RAGE signaling pathway in diabetic complications'), ('hsa04936', 'Alcoholic liver disease'), ('hsa05010', 'Alzheimer disease'), ('hsa05022', 'Pathways of neurodegeneration - multiple diseases'), ('hsa05030', 'Cocaine addiction'), ('hsa05120', 'Epithelial cell signaling in Helicobacter pylori infection'), ('hsa05130', 'Pathogenic Escherichia coli infection'), ('hsa05131', 'Shigellosis'), ('hsa05132', 'Salmonella infection'), ('hsa05133', 'Pertussis'), ('hsa05134', 'Legionellosis'), ('hsa05135', 'Yersinia infection'), ('hsa05140', 'Leishmaniasis'), ('hsa05142', 'Chagas disease'), ('hsa05145', 'Toxoplasmosis'), ('hsa05146', 'Amoebiasis'), ('hsa05152', 'Tuberculosis'), ('hsa05160', 'Hepatitis C'), ('hsa05161', 'Hepatitis B'), ('hsa05162', 'Measles'), ('hsa05163', 'Human cytomegalovirus infection'), ('hsa05164', 'Influenza A'), ('hsa05165', 'Human papillomavirus infection'), ('hsa05166', 'Human T-cell leukemia virus 1 infection'), ('hsa05167', 'Kaposi sarcoma-associated herpesvirus infection'), ('hsa05168', 'Herpes simplex virus 1 infection'), ('hsa05169', 'Epstein-Barr virus infection'), ('hsa05170', 'Human immunodeficiency virus 1 infection'), ('hsa05171', 'Coronavirus disease - COVID-19'), ('hsa05200', 'Pathways in cancer'), ('hsa05202', 'Transcriptional misregulation in cancer'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05207', 'Chemical carcinogenesis - receptor activation'), ('hsa05208', 'Chemical carcinogenesis - reactive oxygen species'), ('hsa05212', 'Pancreatic cancer'), ('hsa05215', 'Prostate cancer'), ('hsa05220', 'Chronic myeloid leukemia'), ('hsa05221', 'Acute myeloid leukemia'), ('hsa05222', 'Small cell lung cancer'), ('hsa05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer'), ('hsa05321', 'Inflammatory bowel disease'), ('hsa05415', 'Diabetic cardiomyopathy'), ('hsa05417', 'Lipid and atherosclerosis'), ('hsa05418', 'Fluid shear stress and atherosclerosis')]"
102724334,['(RefSeq) histone H2B type F-S-like'],21p12,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
114483833,['(RefSeq) H2B.E variant histone 1'],7q36.1,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
128312,['(RefSeq) H2B.U histone 1'],1q42.13,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
158983,['(RefSeq) H2B.W histone 1'],Xq22.2,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
255626,['(RefSeq) H2B clustered histone 1'],6p22.2,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
286436,['(RefSeq) H2B.W histone 2'],Xq22.2,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
3017,['(RefSeq) H2B clustered histone 5'],6p22.2,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
3018,['(RefSeq) H2B clustered histone 3'],6p22.2,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
440689,['(RefSeq) H2B clustered histone 18'],1q21.2,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
54145,['(RefSeq) H2B.S histone 1'],21q22.3,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
121504,['(RefSeq) H4 histone 16'],12p12.3,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
554313,['(RefSeq) H4 clustered histone 15'],1q21.2,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
8294,['(RefSeq) H4 clustered histone 9'],6p22.1,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
8359,['(RefSeq) H4 clustered histone 1'],6p22.2,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
8360,['(RefSeq) H4 clustered histone 4'],6p22.2,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
8361,['(RefSeq) H4 clustered histone 6'],6p22.2,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
8362,['(RefSeq) H4 clustered histone 12'],6p22.1,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
8363,['(RefSeq) H4 clustered histone 11'],6p22.1,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
8364,['(RefSeq) H4 clustered histone 3'],6p22.2,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
8365,['(RefSeq) H4 clustered histone 8'],6p22.2,"[('hsa04613', 'Neutrophil extracellular trap formation'), ('hsa05034', 'Alcoholism'), ('hsa05203', 'Viral carcinogenesis'), ('hsa05322', 'Systemic lupus erythematosus')]"
